Key facts
- Idoven’s last known valuation is $67.3M (Sep 2023).
- It has raised $29.9M; the latest was Later Stage VC in Jul 2025.
- Notable investors include Plug and Play Tech Center, Google for Startups, European Innovation Council, Accel, Insight Partners (New York) — 38 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 38 names
- ·Watchlist + deal alerts for Idoven
- ·The full record, as it builds
Funding rounds
No funding rounds for Idoven are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Idoven
Developer of an artificial intelligence-powered cardiology platform designed to enhance the detection and diagnosis of cardiovascular conditions. The company's platform offers deep learning-based ECG analysis, cloud-based integration, digital biomarkers, and remote monitoring capabilities, enabling healthcare providers, life sciences companies, and medical device manufacturers to identify cardiac abnormalities early and improve patient care outcomes.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2018
- Employees
- 70
- Website
- idoven.ai/
- Ownership
- Privately Held (backing)
Idoven doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Idoven shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Idoven in its N-PORT filings yet. We sweep new filings monthly.